Tm. Rehle et al., EVALUATION OF A QUANTITATIVE DOUBLE ELISA STRATEGY FOR CONFIRMATION AND DIFFERENTIATION OF HIV-INFECTION, Journal of virological methods, 66(2), 1997, pp. 203-209
Citations number
20
Categorie Soggetti
Virology,"Biochemical Research Methods","Biothechnology & Applied Migrobiology
The current HIV pandemic is complicated by the spread of distinct type
s and subtypes of HIV. The currently used conventional diagnostic test
s have shown limitations in the detection of antibodies against all HI
V-1 subtypes, as demonstrated by recent identification of HIV-I subtyp
e O. To evaluate quantitatively the diagnostic potential of a double E
LISA strategy for the detection and partial differentiation of HIV-1,
HIV-I subtype O and HIV-2 infections blood samples were examined at fi
ve different test centers: Blantyre, Malawi; Abidjan and Daloa, Ivory
Coast; Yaounde, Cameroon, Munich, Germany. All tests results, includin
g ELISA extinction values and Western blot profiles, were forwarded to
Munich for final interpretation. An indirect anti-HIV-1/2 ELISA and a
competitive anti-HIV-l ELISA were used in combination for the initial
screening of blood specimens. All anti-HIV positive and anti-HIV nega
tive samples were subjected to immunoblot analysis. Independent of the
diversity of the extinction profiles, and of the test manufacturer, t
he quantitative evaluation of the ELISA extinction values could define
two extinction areas with a 100% predictive value for HIV-I seroposit
ivity and HIV seronegativity: extinction values >2 by the indirect ELI
SA and <0.2 by the competitive ELISA for an anti-HIV-l subtype A to I
positive result; extinction values <0.2 by the indirect ELISA and >1.0
by the competitive ELISA for an anti-HIV negative result. Additionall
y, the quantitative evaluation of the extinction profile provides part
ial information on the HIV-1 subtype as far as the distiction in group
M and group O is concerned. In conclusion, the quantitative evaluatio
n of this double ELISA strategy can reduce the number of blood specime
ns that require additional confirmatory testing in developing countrie
s and can be superior to the immunoblot method during early seroconver
sion. (C) 1997 Elsevier Science B.V.